|
1
|
Bosetti C, Turati F and La Vecchia C:
Hepatocellular carcinoma epidemiology. Best Pract Res Clin
Gastroenterol. 28:753–770. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mitra SA, Mitra AP and Triche TJ: A
central role for long non-coding RNA in cancer. Front Genet.
3:172012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qin R, Chen Z, Ding Y, Hao J, Hu J and Guo
F: Long non-coding RNA MEG3 inhibits the proliferation of cervical
carcinoma cells through the induction of cell cycle arrest and
apoptosis. Neoplasma. 60:486–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyoshi N, Wagatsuma H, Wakana S,
Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino
T and Ishino F: Identification of an imprinted gene, Meg3/Gtl2 and
its human homologue MEG3, first mapped on mouse distal chromosome
12 and human chromosome 14q. Genes Cells. 5:211–220. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista
DL, Gejman R, Ansell PJ, Zhao J, Weng C and Klibanski A: Activation
of p53 by MEG3 non-coding RNA. J Biol Chem. 282:24731–24742. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou S, Wang J and Zhang Z: An emerging
understanding of long noncoding RNAs in kidney cancer. J Cancer Res
Clin Oncol. 140:1989–1995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jia LF, Wei SB, Gan YH, Guo Y, Gong K,
Mitchelson K, Cheng J and Yu GY: Expression, regulation and roles
of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J
Cancer. 135:2282–2293. 2014. View Article : Google Scholar
|
|
12
|
Kang W, Seol HJ, Seong DH, Kim J, Kim Y,
Kim SU, Nam DH and Joo KM: Adenosine potentiates the therapeutic
effects of neural stem cells expressing cytosine deaminase against
meta-static brain tumors. Oncol Rep. 30:1101–1106. 2013.PubMed/NCBI
|
|
13
|
Wu LF, Wei BL, Guo YT, Ye YQ, Li GP, Pu ZJ
and Feng JL: Apoptosis induced by adenosine involves endoplasmic
reticulum stress in EC109 cells. Int J Mol Med. 30:797–804.
2012.PubMed/NCBI
|
|
14
|
Wu LF, Ye YQ, Huang GY, Li HB, Li GP, Pu
ZJ, Wei BL and Feng JL: Involvement of endoplasmic reticulum stress
in adenosine-induced human hepatoma HepG2 cell apoptosis. Oncol
Rep. 26:73–79. 2011.PubMed/NCBI
|
|
15
|
Xiang MQ, Liu LX, De W, Ye YQ, Pu ZJ and
Wu LF: The mechanism of demethylation on adenosine and
homocysteine-induced apoptosis in HepG2 cells. Chin Pharmacol Bull.
30:973–979. 2014.
|
|
16
|
Wu LF, Guo YT, Zhang QH, Xiang MQ, Deng W,
Ye YQ, Pu ZJ, Feng JL and Huang GY: Enhanced antitumor effects of
adenoviral-mediated siRNA against GRP78 gene on adenosine-induced
apoptosis in human hepatoma HepG2 cells. Int J Mol Sci. 15:525–544.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gong C, Popp MW and Maquat LE: Biochemical
analysis of long non-coding RNA-containing ribonucleoprotein
complexes. Methods. 58:88–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lo PH, Tanikawa C, Katagiri T, Nakamura Y
and Matsuda K: Identification of novel epigenetically inactivated
gene PAMR1 in breast carcinoma. Oncol Rep. 33:267–273. 2015.
|
|
19
|
Zhao J, Dahle D, Zhou Y, Zhang X and
Klibanski A: Hyper-methylation of the promoter region is associated
with the loss of MEG3 gene expression in human pituitary tumors. J
Clin Endocrinol Metab. 90:2179–2186. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Gejman R, Mahta A, Zhong Y, Rice
KA, Zhou Y, Cheunsuchon P, Louis DN and Klibanski A: Maternally
expressed gene 3, an imprinted noncoding RNA gene, is associated
with meningioma pathogenesis and progression. Cancer Res.
70:2350–2358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gejman R, Batista DL, Zhong Y, Zhou Y,
Zhang X, Swearingen B, Stratakis CA, Hedley-Whyte ET and Klibanski
A: Selective loss of MEG3 expression and intergenic differentially
methylated region hypermethylation in the MEG3/DLK1 locus in human
clinically nonfunctioning pituitary adenomas. J Clin Endocrinol
Metab. 93:4119–4125. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Benetatos L, Hatzimichael E, Dasoula A,
Dranitsaris G, Tsiara S, Syrrou M, Georgiou I and Bourantas KL: CpG
methylation analysis of the MEG3 and SNRPN imprinted genes in acute
myeloid leukemia and myelodysplastic syndromes. Leuk Res.
34:148–153. 2010. View Article : Google Scholar
|
|
23
|
Shirali S, Aghaei M, Shabani M, Fathi M,
Sohrabi M and Moeinifard M: Adenosine induces cell cycle arrest and
apoptosis via cyclin D1/Cdk4 and Bcl-2/Bax pathways in human
ovarian cancer cell line OVCAR-3. Tumour Biol. 34:1085–1095. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shan X, Fu YS, Aziz F, Wang XQ, Yan Q and
Liu JW: Ginsenoside Rg3 inhibits melanoma cell proliferation
through down-regulation of histone deacetylase 3 (HDAC3) and
increase of p53 acetylation. PLoS One. 9:e1154012014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haupt Y, Maya R, Kazaz A and Oren M: Mdm2
promotes the rapid degradation of p53. Nature. 387:296–299. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu X, Bayle JH, Olson D and Levine AJ: The
p53-mdm-2 auto-regulatory feedback loop. Genes Dev. 7A:1126–1132.
1993. View Article : Google Scholar
|
|
27
|
Michael D and Oren M: The p53-Mdm2 module
and the ubiquitin system. Semin Cancer Biol. 13:49–58. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clegg HV, Itahana Y, Itahana K, Ramalingam
S and Zhang Y: Mdm2 RING mutation enhances p53 transcriptional
activity and p53-p300 interaction. PLoS One. 7:e382122012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Monsalve M, Wu Z, Adelmant G, Puigserver
P, Fan M and Spiegelman BM: Direct coupling of transcription and
mRNA processing through the thermogenic coactivator PGC-1. Mol
Cell. 6:307–316. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ohno M, Kunimoto M, Nishizuka M, Osada S
and Imagawa M: Ku proteins function as corepressors to regulate
farnesoid X receptor-mediated gene expression. Biochem Biophys Res
Commun. 390:738–742. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J,
Wei L, Jin Y, Fu H, Wu Y, et al: Long noncoding RNA MEG3 interacts
with p53 protein and regulates partial p53 target genes in hepatoma
cells. PLoS One. 10:e01397902015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shamanna RA, Hoque M, Pe'ery T and Mathews
MB: Induction of p53, p21 and apoptosis by silencing the NF90/NF45
complex in human papilloma virus-transformed cervical carcinoma
cells. Oncogene. 32:5176–5185. 2013. View Article : Google Scholar
|
